Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
…continuation of investment in discovery to build a sustainable model for therapeutic innovation. Odyssey has already built a comprehensive drug discovery and development platform merging both computational and experimental technologies,…